OQROSign up free
Politician trade (House)

Baxter International (BAX): Rep. Debbie Wasserman Schultz (FL25) disclosed a purchase $1K–$15K

Rep. Debbie Wasserman Schultz (FL25) disclosed a purchase of Baxter International in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
2 days
Disclosure lag
Traded
Nov 18, 2024
Disclosed
Nov 20, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 18, 2024 · this disclosureCongressDisclosed purchase of BAX — reported range $1,001 - $15,000

What came next

  1. Feb 25, 2025FDARecall: Baxter TruSystem 7500 Hybrid Plus (FC), Product Code 1854087
  2. Feb 25, 2025FDARecall: Baxter Mobile column TruSystem 7500 U, Product Code 1730720
  3. Feb 25, 2025FDARecall: Baxter TruSystem 7500, Product Code 4091000
  4. Feb 25, 2025FDARecall: Baxter Stationary column TruSystem 7500, Product Code 1717020
  5. Feb 25, 2025FDARecall: Baxter TruSystem 7500 Hybrid (MC), Product Code 1773204
  6. Feb 25, 2025FDARecall: Baxter TruSystem 7500 Hybrid (SC), Product Code 1854086
  7. Feb 25, 2025FDARecall: Baxter Stationary column TruSystem 7500 U, Product Code 1730731
  8. Feb 25, 2025FDARecall: Baxter TruSystem 7500 Hybrid MR IMRIS, Product Code 2067886
  9. Feb 25, 2025FDARecall: Baxter Operating table column TS7500 MOBIUS, Product Code 1704695
  10. Feb 25, 2025FDARecall: Progressa Bed Surfaces, intended to be used to treat or prevent pulmonary or other complications associated with immobility, Product Codes P7520A19, P7520A20S,…
  11. Feb 25, 2025FDARecall: Baxter TruSystem 7500 Hybrid (FC), Product Code 1854085
  12. Feb 28, 2025FDAFDA drug approval: Epinephrine Bitartrate IN 0.9% Sodium Chloride
  13. Feb 28, 2025FDAFDA device clearance: Intravascular Extension Sets and Accessories
  14. Mar 3, 2025FDARecall: Baxter NovumIQ Syringe INFUSION SYSTEM , REF 40800BAXUS
  15. Mar 14, 2025FDAFDA device clearance: Solution Administration Sets
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Baxter International

OQRO holds no insider, Congress, fund or contract record for Baxter International dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BAX page.

Other recent filings by Rep. Debbie Wasserman Schultz (FL25)

The full history of Rep. Debbie Wasserman Schultz (FL25) is on the profile page.

How this filing works

Explore the data

Other disclosures at Baxter International

Everything OQRO holds on this company is on its BAX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data